Working… Menu

ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04032847
Recruitment Status : Recruiting
First Posted : July 25, 2019
Last Update Posted : September 20, 2021
Information provided by (Responsible Party):
Achilles Therapeutics UK Limited

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 1, 2023
Estimated Study Completion Date : December 31, 2023